论文部分内容阅读
本文作者阐述了已经发表的免疫标志的3个积分系统在血液病恶性肿瘤定性中的价值。 其一是用来诊断双表型白血病,并区分其与那些更倾向于忽淋(ALL)或急粒(AML),但伴有另一系异常表达的白血病。此积分系统包括B系的mb-
The authors describe the value of three integrated systems of published immunological markers in the qualitative characterization of hematological malignancies. One is to diagnose biphenotypic leukemia and to distinguish it from those leukemias that are more prone to ALL or AML, but with abnormal expression in another. This integral system includes B series mb-